Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 4.31 M4.37 M3 M2.65 M3.27 M 13.29 M Research & development 0000— — Operating income -5.86 M-6.37 M-5.88 M-5.56 M-5.68 M -23.5 M Non-Operating Income, Total -1.7 M-1.08 M-762.03 K-13.6 M-3.58 M -19.03 M Interest expense, net of interest capitalized 1.11 M1.21 M1.22 M5.19 M953.08 K 8.57 M Non-Operating Income, excl. Interest Expenses -1.79 M-1.03 M-759.14 K-13.66 M-3.59 M -19.03 M Unusual income/expense 87.4 K-52.46 K-2 88352.27 K3 145 70 Pretax income -8.68 M-8.66 M-7.86 M-40.83 M-11.15 M -68.5 M Equity in earnings ————— — Taxes 00000 0 Non-controlling/minority interest ————— — After tax other income/expense -95.25 K-110.44 K-88.64 K-241.41 K-91.87 K -532.36 K Net income before discontinued operations -7.57 M-7.45 M-6.64 M-19.17 M-9.27 M -42.53 M Discontinued operations ————— — Net income -7.57 M-7.45 M-6.64 M-19.17 M-9.27 M -42.53 M Dilution adjustment ————0 — Preferred dividends ————191.25 K — Diluted net income available to common stockholders -7.57 M-7.45 M-10.07 M-44.73 M-9.46 M -71.71 M Basic earnings per share (Basic EPS) -20.16-18.72-20.8-24.23-2.46 -66.21 Diluted earnings per share (Diluted EPS) -20.16-18.72-20.8-24.23-2.46 -66.21 Average basic shares outstanding 381.21 K402.88 K484.81 K835.23 K3.84 M — Diluted shares outstanding 381.21 K402.88 K484.81 K835.23 K3.84 M — EBITDA -5.38 M-5.8 M-5.29 M-4.92 M-5.06 M -21.06 M EBIT -5.86 M-6.37 M-5.88 M-5.56 M-5.68 M -23.5 M Cost of revenue 1.24 M3.5 M4.27 M3.33 M1.99 M 13.09 M Other cost of goods sold 1.24 M3.5 M4.27 M3.33 M1.99 M 13.09 M Depreciation & amortization (cash flow) 480.38 K574.56 K590.82 K699.07 K624.79 K 2.49 M